外体的非编码RNA:调节肺癌骨转移及其临床应用前景
Qing Yang1, Wei Wang2, Dezhou Cheng3
1Nuclear Medicine Department, The First Affiliated Hospital of Yangtze University, Jingzhou 434000, Hubei, China; Health Science Center of Yangtze University, Jingzhou 434023, Hubei, China.
Translational oncology
|May 26, 2024
概括
携带非编码RNA (ncRNA) 的外基因组在肺癌骨转移中起着关键作用. 了解这些机制为这种侵袭性癌症提供了新的诊断和治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 纳米技术 纳米技术
背景情况:
- 肺癌经常转移到骨,导致严重的并发症和不良预后.
- 外体,纳米粒子参与细胞间通信,携带生物活性分子,如非编码RNA (ncRNAs) 对于骨重塑至关重要.
- 外基因源的ncRNA与肺癌的骨转移有关.
研究的目的:
- 审查肺癌骨转移中的外体携带ncRNAs的调节机制.
- 突出外体在诊断和治疗肺癌骨转移中的临床潜力.
主要方法:
- 文献综述侧重于对肺癌骨转移中的外体衍生蛋白,lncRNA和microRNA的研究.
- 分析ncRNAs在细胞间通信和骨重塑中的作用.
主要成果:
- 外基因组促进了影响骨重塑和转移的ncRNAs的运输.
- 外体携带的特定ncRNA在肺癌骨转移的进展中至关重要.
- 外体显示出作为生物标志物和治疗输送工具的前景.
结论:
- 异构体衍生的ncRNAs是肺癌骨转移的关键调节者.
- 针对外体介导的ncRNA通信提供了一个新的治疗途径.
- 外体提供了改善肺癌骨转移的诊断和治疗的潜力.
更多相关视频
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
6.8K
10:33An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue
Published on: February 3, 2023
1.3K
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
MicroRNAs
21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
